chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Red rash on stomach and chest. Also developed rash at 4 mo shots (not reported, same provider).
About 1  hour after receiving my first dose of the Moderna vaccine for COVID-19, I started feeling extreme pain in my left shoulder and arm, where the shot was administered. The pain continued to intensify throughout the day and night and was 10/10 on a pain scale. In addition, I began to lose my ability to lift my left arm or use it. It became so weak that I had to use my right hand/arm to pick up my left arm to move it. My left arm was 'hanging and drooping' and my left shoulder was very  noticeably lower then my right shoulder. I called my primary care and employee health. My primary care doctor advised me to take advil and go to urgent care if the pain persisted and worsened. I could not sleep at all that evening of 12/29/20 because the pain was so intense and I had to keep picking my left arm up with my right arm to keep re-adjusting to try and get comfortable. The next morning I went to an orthopedic urgent care where I was diagnosed with nerve damage from the shot and prescribed Methylprednisolone 4mg dosepack. The doctor who saw me explained that he could not assess the extent of the damage at this time because my nerves were so agitated and inflamed. He scheduled a follow up visit with me for Thursday, January 7th and stated he will then proceed with an MRI and further investigation to assess the extent of the nerve damage.  During the days that followed my immunization, I was unable to do anything with my left arm and was dependent on my husband to help me get dressed, showered, household chores, etc. It is unknown at this time whether this will be temporary or permanent damage and disability.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Hypotension-Mild, Systemic: Vomiting-Mild, Systemic: Weakness-Mild, Additional Details: pt felt dizzy and lighheaded when he waited for his rider 30 minutes post vaccination.bp 70/40,hr45, positioned on the floor with legs elevated, bp 90/50, hr 92. pt is diabetic, didn't eat breakfast, vomitting.
2 hours after my 1st Pfizer vaccine. I developed TMJ in my left jaw(I have never had this and did not have symptoms prior to my 1st shot). I saw a Dr. That same week on Thursday at health care company who confirmed it and provided muscle relaxers.  The following week when I saw my acupuncturist for it she said I was the 4th person she had seen with a muscle spasm reaction to the vaccine. Today 4/30 i still have symptoms present but they are not debilitating.
Patient received extra dose of HPV vaccine. Patient had already received two doses:  1st dose: 9/20/2021 (9 y.o) 2nd dose: 11/1/2022 (10 y.o)
Miscarriage. Unknown if due to vaccine, but I received vaccine at 6 weeks 3 days and miscarried at 6 weeks 6 days.; 3rd dose booster; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A 31 year-old female patient (pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), administered in arm left, administration date 08Dec2021 (Batch/Lot number: unknown) at the age of 31 years as dose 3 (booster), single for covid-19 immunization at a workplace clinic. Relevant medical history included: "Hypothyroid" (unspecified if ongoing). Date of last menstrual period: 25Oct2021. The patient was 6 weeks and 3 days pregnant at the time of exposure to bnt162b2. The patient was 6 weeks and 6 days pregnant at the event onset. The patient is expected to deliver a baby(s) on 01Aug2022. Concomitant medication(s) included: LEVOTHYROXINE and unspecified prenatal medication. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown), for COVID-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown.), for COVID-19 immunization. The following information was reported: IMMUNISATION (medically significant) with onset 08Dec2021, outcome "unknown", described as "3rd dose booster"; ABORTION SPONTANEOUS (medically significant) with onset 11Dec2021, outcome "recovered with sequelae", described as "Miscarriage. Unknown if due to vaccine, but I received vaccine at 6 weeks 3 days and miscarried at 6 weeks 6 days.". The pregnancy resulted in spontaneous abortion. Therapeutic measures were taken as a result of abortion spontaneous which includes D&C. The patient had no COVID prior to vaccination and has not been tested post vaccination.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient felt dizzy while walking to car, and then he fainted, was brought back in to office, MA checked vs, RN checked BS (69). Patient drank a glass of water. Drank apple juice ate peanut butter and crackers. Felt better and went home.
We gave the patient a dose of Pfizer when they should've received their second dose of Moderna.
Breakthrough case admission after 2 vaccines Moderna 11/28/21 Lot# 058H21A;  Moderna 8/9/22 Lot# 056A22A
Punctured vial stored in the refrigerator more than 24 hours; Received expired first primary dose beyond  12 hours post puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired first primary dose beyond  12 hours post puncture) and PRODUCT STORAGE ERROR (Punctured vial stored in the refrigerator more than 24 hours) in a 38-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jul-2022 at 9:30 AM, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 21-Jul-2022,  after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired first primary dose beyond  12 hours post puncture). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Punctured vial stored in the refrigerator more than 24 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired first primary dose beyond  12 hours post puncture) and PRODUCT STORAGE ERROR (Punctured vial stored in the refrigerator more than 24 hours) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Date the vial was initially stored in the refrigerator on 13-JUL-2022. Date and Time when the vial was first punctured on 20-JUL-2022 at 07:45 AM. The vial was in the refrigerator post puncture for 24 hours. The vial did not undergo any temperature excursions.  No treatment information was reported.
Patient arrived with chest pain to the emergency department. ECG demonstrated diffuse ST elevation consistent with pericarditis.  Cardiac biomarkers to include CK and troponin were elevated thereby confirming myopericarditis.
Pt recvd 2nd dose Hep B vax 23JUL91 & 3 hrs post vax pt c/o sleepiness, blurred vision, & beige outs occuring 3 to 4 times for 1 min ea; became light-headed w/inability to form complete sentence; felt drugged; fatigued w/front h/a, diarrhea
10 days post vax, the infant developed a cough, fevers, and irritability. The infant was seen by a physician, and a chest x-ray was performed. The x-ray revealed an enlarged heart which had been normal size at birth. A diagnosis of cardiomyopathy was made, and the infant was hospitalized at at tertiary car center to undergo heart transplantation.
Not sure if the patient received the full dose; A spontaneous report was received from a health professional concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the event, not sure if the patient received the full dose.  The patient's medical history was not provided. No relevant concomitant medications were reported.    On 05 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 039K20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.   On 05 Jan 2021 at 10:15 am, during the administration of the vaccine, some of dose fell out onto the chair. The health professional was not sure if the patient received the full dose. Treatment information was not provided.   Action taken with mRNA-1273 in response to the event was not provided.   The outcome of the event, not sure if the patient received the full dose, was considered resolved on 05 Jan 2021.; Reporter's Comments: This is a report from a HCW who was ' Not sure if the patient received the full dose '(incomplete dose administered) mRNA-1273, lot # 039K20A. There were no reported adverse events associated with this case of incomplete dose administered
This spontaneous report as received from an immunization program refers an patient of unknown age and gender. On an unknown date the patient was vaccinated with a dose of improperly stored GARDASIL (route, site, dose, strength not reported, lot # H021861, exp. date: 09-OCT-2015). This is one of several reports received from the same source (linked MARRS#: 1311USA000056, 1310USA015119, 1311USA000071, 1310USA015417, 1310USA014897, 1311USA000012, 1310USA014858, 1310USA014850, 1310USA014891, 1310USA014870, 1310USA015113, 1311USA000289, 1311USA000282, 1310USA014874, 1310USA014861, 1310USA014881, 1311USA000059, 1310USA014866, 1310USA014868, 1310USA014883, 1310USA015422, 1310USA015165, 1311USA000069, 1310USA015424, 1311USA000058, 1311USA004931, 1311USA000042, 1311USA000065, 1310USA014888, 1311USA000013, 1310USA015170, 1311USA000014, 1310USA015153, 1310USA015090, 1311USA000067, 1311USA000064, 1311USA000020, 1311USA000021, 1311USA000040, 1310USA015096, 1311USA000022, 1310USA015101, 1310USA014853, 1311USA000739, 1311USA000075, 1310USA014895.  Additional information is not expected.
vaccination site erythema; vaccination site pain; Vaccine underdoes; syringe connection issue; A spontaneous report was received from a consumer concerning a 67-years-old male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) .  The patient medical history was not provided. Concomitant medications were not provided.   On 15 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscular in the left upper arm, for prophylaxis of COVID-19 infection.   On 15 Feb 2021, during vaccination patient felt the dose dripping down the arm, 8 hours after vaccination, the patient had pain around the deltoid area (shoulder and arm) on the left side  and noticed a bruise at the injection site.  No treatment medications were reported.   Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Patient is experiencing pain and limited movement in right shoulder 2+ weeks after immunization. Recommended NSAIDS, ice,  and referred to MD.
Primary smallpox vaccination. Has diffuse maculopapular lesions on thorax and upper extremities consistent with generalized vaccinia.  Mild malaise for 2 days.  Vaccination site with 5 cm surrounding erythema. Small pustules in the center of most of his thoracic lesions, so qualifies as "possible generalized vaccinia."
Around 11pm patient had a fever of 103.  Right arm was extremely sore Rash is now on right arm
1 day following vax, pt devel inj site rxn w/"cellulitis". Pt seen in ER and tx w/antibiotic.
Experienced sharp pain in leg presenting as a "charlie horse". Patient was admitted to hospital after worsening symptoms and is currently taking eliquis daily.
Left arm all the way up to neck, upper chest, shoulder and down arm have been sore with decreased strength, increased pain since injection given. Lasting at least 12 days now. Still has mobility/range of motion to arm/shoulder.
Information has been received from a physician concerning a 72 year old male patient with no pertinent medical history and with seasonal allergies who on 05-MAY-2009 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot # 1448X, validated for ROTATEQ subcutaneously. Concomitant therapy included FLONASE and VIAGRA. It was reported that two days later (on 07-MAY-2009) the patient developed a shingles rash on the left leg. The patient sought medical attention with an office visit. Diagnosis of shingles was confirmed by dermatologist. There were no laboratory diagnostic tests performed. It was reported that the patient had not recovered at the time of the report. Additional information has been requested.
Information has been received from a nurse practitioner concerning a 6 month old female with no pertinent medical history reported or drug reactions or allergies reported as none who on 22-APR-1993 was vaccinated with first adult dose of RECOMBIVAX HB (lot # not reported). On 19-JUN-1993 she received second adult dose of RECOMBIVAX HB (lot # not reported). On 11-OCT-1993 she received third adult dose of RECOMBIVAX HB (lot # not reported). There was no concomitant medication. On 03-MAY-2010 the patient was found to have negative hepatitis B antibody titers. The patient sought unspecified medical attention. The outcome of negative hepatitis B antibody titers was unknown. Additional information has been requested.
My knees were swollen and in pain and they felt really tight I thought I had just overexerted myself walking. It got worse and I was icing them and taking ibuprofen. I went to the Dr after about 7 days.  They did not find anything wrong other than inflammation and swelling. I received cortical steroid injections in both knees because the pain was so bad. I was prescribed tramadol, but I did not receive the prescription and did not go back for it. The pain subsided a little but the swelling and inflammation lasted a few more days. I just took ibuprofen and Tylenol. It was about a week or so before I noticed a difference and was able to walk again.
This spontaneous report as received from a Medical Assistant refers to a patient of unknown age and gender. On 07-JUL-2015, the patient was vaccinated with an improperly stored dose of M-M-R II lot # K016154 with exp. 24-SEP-2016, (route and dose were not provided). Noa adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Increased bruising through November and then dx'd with ITP on 12/11/01. Treated with steroids and IVIG. Not yet recovered. *F/UP report on 3/21/03: Adverse event was ITP - child is still under care of red tematology for ITP.*
Came in with weakness of lower extremities with paresthesias and loss of sensation following flu shot, 1 week prior.
This is an instance of breakthrough COVID-19 disease after which death occurred.   The individual was vaccinated with the Pfizer product on 03/18/2021 and 04/08/2021. They became symptomatic for COVID-19 disease on 01/09/2022 and tested positive via PCR COVID-19 test on 01/10/2022. They were tested again upon hospital admission later on 01/10/2022 which was also positive via PCR. They were discharged from hospital on 01/14/2022 but then seen in Emergency Department on 01/20/2022 and were admitted to hospital again, they died later on the same day (on 01/22/2022). Rib fracture is listed on death certificate, as is COVID-19 pneumonia.
My face went numb 30min after injection.; Then I got pain in my head; Then I got pain in my head and neck; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 05May2021 at 13:00 (at the age of 28-year-old) as a single dose of COVID-19 immunisation. Medical history included ehlers-danlos syndrome, postural orthostatic tachycardia syndrome and hashimoto's thyroiditis. The patient had no known allergies to food, medications or other products. The patient previously took paracetamol (TYLENOL) from unknown dates for relieving pain within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 13:30 thirty minutes after injection, the patient experienced numbness in face, then she got pain in her head and neck similar to whiplash. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measure was taken as a result of the reported event numbness in face. Therapeutic measures were taken as a result of the reported events pain in head and neck which included treatment with motrin and tylenol from an unknown dates. The clinical outcome of the events numbness in face, pain in head and neck lasted for 10 days and recovered with sequelae on 15May2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient received vaccines at 2:30 PM and at 3:00 was back in office. Face swollen (lips, eyes, etc). Gave Epipen and Albuterol nebulizer.
tachycardia; in a lot of stress; This is a spontaneous report from a contactable nurse from a Pfizer-sponsored program. A 52-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm on May2021 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunisation. Medical history included family history of high blood pressure. The patient's concomitant medications were not reported. The patient experienced tachycardia on an unspecified date, the patient was in a lot of stress in May2021. The patient did not get admitted to the hospital and that the patient was released from the emergency room. The cardiologist has done a couple of EKGs and a heart monitor and nothing has shown up so far. Outcome of event tachycardia was recovered, in a lot of stress was recovered in May2021. Event tachycardia required Emergency Room Visit. Event tachycardia was reported as serious due to medically significant.  Information on the lot/batch number has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported tachycardia cannot be excluded based on temporal relationship. The patient's stress might also have contributed to the event. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
diagnosed to have pneumonia; hard cold; chest congestion; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PNEUMONIA (diagnosed to have pneumonia) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PNEUMONIA (diagnosed to have pneumonia) (seriousness criterion medically significant), NASOPHARYNGITIS (hard cold), RESPIRATORY TRACT CONGESTION (chest congestion), PYREXIA (fever) and CHILLS (chills). At the time of the report, PNEUMONIA (diagnosed to have pneumonia), NASOPHARYNGITIS (hard cold), RESPIRATORY TRACT CONGESTION (chest congestion), PYREXIA (fever) and CHILLS (chills) outcome was unknown.            Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Very limited information regarding these events has been provided at this time. No further information is expected at this time. Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Very limited information regarding these events has been provided at this time. No further information is expected at this time.
Several days post vax, the pt experienced unioccular ptosis which was worse later in the day than in the morning.
This case was reported by a nurse via call center representative and described the occurrence of influenza-like symptoms in a adolescent female patient who received BEXSERO. On in unknown date, the patient received the 1st dose of BEXSERO .5 ml. On an unknown date, unknown after receiving BEXSERO, the patient experienced influenza-like symptoms. BEXSERO was discontinued (Dechallenge was positive). On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved. The reporter considered the influenza-like symptoms to be almost certainly related to BEXSERO. Additional details were reported as follows: The age at vaccination was not reported. The patient was high school aged. The patient received unknown concomitant medication. The patient experienced severe flu like symptoms after receiving BEXSERO. The patient was taken to the emergency room but was not hospitalized. After a couple of days the symptoms resolved.
At 3 hrs after shots child had peripheral cyanosis. It resolved in 30-60 min. Family went to ER.
2 days after my second shot I broke out in Hives and welts down my torso, Arms, and legs. I went to urgent care and they gave me a shot of prednisone and gave me a pack of the same steroid to take over the next 6 days they also prescribed some prescription Claritin and Famotidine.. The following day 4/16/21 around 1130pm I woke up to my face being swollen as well as my tongue. I was taken to the ER where the triage unit gave me epinephrine as well as another steroid to stabilize the swelling as I was having trouble breathing. Once stabilized I was released and took 50 mg of Benadryl every 6 hours as well as the Claritin, famotidine, and the prednisone. I had hives for a few days after and followed up with my primary doctor, but as of today I feel like i am back to normal.